-
Je něco špatně v tomto záznamu ?
Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant
K. Uriu, J. Ito, J. Zahradnik, S. Fujita, Y. Kosugi, G. Schreiber, Genotype to Phenotype Japan (G2P-Japan) Consortium, K. Sato
Jazyk angličtina Země Spojené státy americké
Typ dokumentu dopisy
NLK
ProQuest Central
od 2001-08-01 do Před 2 měsíci
Nursing & Allied Health Database (ProQuest)
od 2001-08-01 do Před 2 měsíci
Health & Medicine (ProQuest)
od 2001-08-01 do Před 2 měsíci
Public Health Database (ProQuest)
od 2001-08-01 do Před 2 měsíci
- MeSH
- COVID-19 * MeSH
- lidé MeSH
- SARS-CoV-2 * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- dopisy MeSH
1st Medical Faculty at Biocev Charles University Prague Czechia
CREST Japan Science and Technology Agency Kawaguchi Japan
Department of Biomolecular Sciences Weizmann Institute of Science Rehovot Israel
Graduate School of Frontier Sciences The University of Tokyo Kashiwa Japan
Graduate School of Medicine The University of Tokyo Tokyo Japan
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23003936
- 003
- CZ-PrNML
- 005
- 20230425141007.0
- 007
- ta
- 008
- 230418s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/S1473-3099(23)00051-8 $2 doi
- 035 __
- $a (PubMed)36736338
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Uriu, Keiya $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
- 245 10
- $a Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant / $c K. Uriu, J. Ito, J. Zahradnik, S. Fujita, Y. Kosugi, G. Schreiber, Genotype to Phenotype Japan (G2P-Japan) Consortium, K. Sato
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a SARS-CoV-2 $7 D000086402
- 650 12
- $a COVID-19 $7 D000086382
- 655 _2
- $a dopisy $7 D016422
- 700 1_
- $a Ito, Jumpei $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
- 700 1_
- $a Zahradnik, Jiri $u Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel; First Medical Faculty at Biocev, Charles University, Prague, Czechia
- 700 1_
- $a Fujita, Shigeru $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
- 700 1_
- $a Kosugi, Yusuke $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
- 700 1_
- $a Schreiber, Gideon $u Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel
- 700 1_
- $a Sato, Kei $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan; Collaboration Unit for Infection, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan; CREST, Japan Science and Technology Agency, Kawaguchi, Japan. Electronic address: keisato@g.ecc.u-tokyo.ac.jp
- 710 2_
- $a Genotype to Phenotype Japan (G2P-Japan) Consortium
- 773 0_
- $w MED00006437 $t The Lancet. Infectious diseases $x 1474-4457 $g Roč. 23, č. 3 (2023), s. 280-281
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36736338 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425141003 $b ABA008
- 999 __
- $a ok $b bmc $g 1924540 $s 1190145
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 23 $c 3 $d 280-281 $e 20230131 $i 1474-4457 $m Lancet. Infectious diseases $n Lancet Infect Dis $x MED00006437
- LZP __
- $a Pubmed-20230418